Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005286-25-000120
Filing Date
2025-09-04
Accepted
2025-09-04 16:42:03
Documents
1
Period of Report
2025-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757018519.html 4  
1 FORM 4 wk-form4_1757018519.xml 4 3342
  Complete submission text file 0001005286-25-000120.txt   4812
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3515 LYMAN BLVD CHASKA MN 55318
Business Address
Lake Ryan David (Reporting) CIK: 0001450325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27446 | Film No.: 251293983